The data shown below were collected from the profiles of 217 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Drug repurposing candidates to treat core symptoms in autism spectrum disorder
|
---|---|
Published in |
Frontiers in Pharmacology, September 2022
|
DOI | 10.3389/fphar.2022.995439 |
Pubmed ID | |
Authors |
Elise Koch, Ditte Demontis |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 8 | 4% |
United Kingdom | 4 | 2% |
France | 4 | 2% |
India | 3 | 1% |
Poland | 2 | <1% |
Ireland | 2 | <1% |
Australia | 2 | <1% |
Colombia | 1 | <1% |
Philippines | 1 | <1% |
Other | 17 | 8% |
Unknown | 173 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 191 | 88% |
Scientists | 15 | 7% |
Practitioners (doctors, other healthcare professionals) | 10 | 5% |
Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 22% |
Student > Bachelor | 2 | 11% |
Unspecified | 1 | 6% |
Other | 1 | 6% |
Lecturer | 1 | 6% |
Other | 2 | 11% |
Unknown | 7 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 3 | 17% |
Agricultural and Biological Sciences | 2 | 11% |
Medicine and Dentistry | 2 | 11% |
Psychology | 2 | 11% |
Unspecified | 1 | 6% |
Other | 2 | 11% |
Unknown | 6 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 449. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2024.
All research outputs
#66,176
of 26,557,909 outputs
Outputs from Frontiers in Pharmacology
#20
of 20,601 outputs
Outputs of similar age
#1,990
of 440,101 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 1,511 outputs
Altmetric has tracked 26,557,909 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,601 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,101 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1,511 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.